The global in vitro diagnostics (IVD) market size is
expected to reach USD 97.01 billion by 2022, according to a new report by Grand
View Research, Inc., rising at a CAGR of 6.8% during the forecast period.
Increasing incidence of sexually transmitted and gastrointestinal diseases
coupled with surging demand for large-scale screening, particularly for cancer,
is stimulating the growth of the market. IVD helps in detecting whether a
particular medicine or treatment would work on a patient.
Constant innovations and advancements play a pivotal role in the
development of the market. IVD is being increasingly used in every stage of the
patient care and nearly each healthcare setting. Though, most of these tests
are remotely performed, making their presence unnoticed.
Various organizations are functioning to monitor the market. For
instance, BIVDA is an association of companies with high involvement and
interest and represents manufacturers and distributors functioning in the U.K.
Rapidly changing healthcare environment and growing acknowledgment of
diagnostics role in patient care, along with rising awareness regarding
importance of early diagnosis of chronic diseases, are likely to boost the
growth of the IVD market.
Surging demand for point-of-care detection and identification of various
infectious diseases such respiratory tract infections, including Legionnaires’
disease, RSV, influenza, and pneumonia, coupled with pathogens causing
filariasis and malaria, is providing a significant push to the market.
Full
Research Report On In Vitro Diagnostics (IVD) Market Analysis:
https://www.grandviewresearch.com/industry-analysis/in-vitro-diagnostics-ivd-market
Further key findings from the report suggest:
·
Reagents were the largest segment in 2016
and are expected to show the fastest growth over the forecast period owing to
rising R&D activities pertaining to self-test and point-of-care products
·
Infectious disease dominated the market in
2016 due to increasing incidence of infectious diseases such as pneumonia,
tuberculosis, and HIV.
·
Hospitals were one of the largest segment
in 2016 owing to rising number of hospitalized patients
·
North America dominated the IVD market in
2016 due to rising prevalence of chronic disorders such as respiratory diseases
and cancer in this region
·
Asia Pacific is expected to be the fastest
growing region over the forecast period. Rising per capita healthcare
expenditure, government initiatives, and growing clinical research activities
for advanced diagnostics are likely to drive the regional market.
View More Reports
Of This Category By Grand View Research At: https://www.grandviewresearch.com/industry/healthcare
Grand View Research has segmented the global in vitro diagnostics market
report on the basis of technology, application, and region:
In Vitro
Diagnostics Product Outlook (Revenue, USD Million, 2013 - 2022)
·
Instruments
·
Reagents
·
Software
In Vitro
Diagnostics Application Outlook (Revenue, USD Million, 2013 - 2022)
·
Infectious Disease
·
Diabetes
·
Cancer
·
Cardiology
·
Nephrology
·
Autoimmune Diseases
·
Drug Testing
·
Others
In Vitro
Diagnostics Technology Outlook (Revenue, USD Million, 2013 - 2022)
·
Immunology
·
Hematology
·
Clinical Chemistry
·
Molecular Diagnostics
·
Coagulation
·
Microbiology
·
Others
In Vitro
Diagnostics End-use Outlook (Revenue, USD Million, 2013 - 2022)
·
Hospital
·
Laboratory
·
Home Care
·
Others
In Vitro
Diagnostics Regional Outlook (Revenue, USD Million, 2013 - 2022)
·
North America
·
Europe
·
Asia Pacific
·
RoW
Access Full Press Release Of This Report By
Grand View Research:
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
